# RIGENERA 2.0 Trial

> **NCT02502747** · PHASE2 · WITHDRAWN · sponsor: **Catholic University of the Sacred Heart**

## Conditions studied

- Anterior Myocardial Infarction
- Heart Failure

## Interventions

- **DRUG:** rhu G-CSF
- **DRUG:** optimal standard of care
- **PROCEDURE:** Myocardial Contrast Echocardiography

## Key facts

- **NCT ID:** NCT02502747
- **Lead sponsor:** Catholic University of the Sacred Heart
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01
- **Primary completion:** 2021-10
- **Final completion:** 2021-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** slow enrolment
- **Last updated:** 2022-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02502747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02502747, "RIGENERA 2.0 Trial". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02502747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*